High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms

•COVID-19 patients show a broad spectrum of neurological manifestations.•SARS-CoV-2 is scarcely detected in cerebrospinal fluid.•Viral-triggered autoimmune responses may lead to neurological symptoms.•Immunotherapy should be considered in CSF autoantibody-positive Covid-19 patients. COVID-19 intensi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Brain, behavior, and immunity behavior, and immunity, 2021-03, Vol.93, p.415-419
Hauptverfasser:	Franke, Christiana, Ferse, Caroline, Kreye, Jakob, Reincke, S. Momsen, Sanchez-Sendin, Elisa, Rocco, Andrea, Steinbrenner, Mirja, Angermair, Stefan, Treskatsch, Sascha, Zickler, Daniel, Eckardt, Kai-Uwe, Dersch, Rick, Hosp, Jonas, Audebert, Heinrich J., Endres, Matthias, Ploner, J. Christoph, Prüß, Harald
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Autoantibodies - cerebrospinal fluid Autoantibody Autoantigens Autoimmunity Central Nervous System Diseases - virology COVID-19 COVID-19 - cerebrospinal fluid CSF Encephalitis Female Humans Male Middle Aged Neurology Short Communication Viral-triggered
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!